Although typical apoptosis is non-immunogenic, studies indicated that, under certain conditions such as caspase deficiency, apoptosis could indeed trigger adaptive anti-tumor or anti-viral immune responses by activating NF-κB signaling (66) and cGAS/STING pathway, respectively (67, 68). This evidence concerns the gene NFKB1 and neoplasm.